A Study to Test Whether Different Doses of BI 690517 Alone or in Combination With Empagliflozin Improve Kidney Function in People With Chronic Kidney Disease
Clinical trial NCT05182840 · COMPLETED
Trial details
- NCT number
- NCT05182840
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-11
- Primary completion
- 2023-06-19
- Enrollment
- 714
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.